Natural Capsules (BOM:524654) Cyclically Adjusted Revenue per Share: ₹161.94 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524654 Natural Capsules Ltd BOM:524654
49 GF Score
Price ₹226.05
GF Value ₹296.93
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Natural Capsules Cyclically Adjusted Revenue per Share?

Natural Capsules BOM:524654 +6.61% 49 Cyclically Adjusted Revenue per Share is ₹161.94 as of Jun. 2026. GuruFocus rates BOM:524654 with a GF Score™ of 49/100 and a GF Value™ of ₹296.93 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Natural Capsules's adjusted revenue per share for the three months ended in Jun. 2026 was ₹47.069. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹161.94 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Natural Capsules's average Cyclically Adjusted Revenue Growth Rate was 8.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Natural Capsules was 7.40% per year. The lowest was 4.20% per year. And the median was 4.70% per year.

As of today (2026-09-04), Natural Capsules's current stock price is ₹226.05. Natural Capsules's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹161.94. Natural Capsules's Cyclically Adjusted PS Ratio of today is 1.40.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Natural Capsules was 4.78. The lowest was 0.53. And the median was 1.97.


Natural Capsules  (BOM:524654) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Natural Capsules's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=226.05/161.94
=1.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Natural Capsules was 4.78. The lowest was 0.53. And the median was 1.97.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Natural Capsules Cyclically Adjusted Revenue per Share Related Terms


Natural Capsules Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Natural Capsules's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Natural Capsules Cyclically Adjusted Revenue per Share Chart

Natural Capsules Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 127.90 138.60 143.32 146.80 156.72

Natural Capsules Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 149.47 152.12 153.45 156.72 161.94

BOM:524654 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Natural Capsules's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Natural Capsules Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Natural Capsules's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Natural Capsules's Cyclically Adjusted PS Ratio falls into.


BOM:524654
49GF Score
Natural Capsules Ltd BOM:524654
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Natural Capsules Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Natural Capsules's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=47.069/167.3573*167.3573
=47.069

Current CPI (Jun. 2026) = 167.3573.

Natural Capsules Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 13.828 105.961 21.840
201612 19.309 105.196 30.719
201703 18.519 105.196 29.462
201706 14.710 107.109 22.984
201709 22.897 109.021 35.149
201712 18.866 109.404 28.860
201803 20.622 109.786 31.436
201806 18.907 111.317 28.425
201809 18.732 115.142 27.227
201812 20.034 115.142 29.119
201903 17.774 118.202 25.165
201906 18.723 120.880 25.922
201909 20.418 123.175 27.742
201912 22.179 126.235 29.404
202003 16.932 124.705 22.723
202006 21.055 127.000 27.746
202009 24.559 130.118 31.588
202012 34.772 130.889 44.460
202103 28.279 131.771 35.916
202106 41.209 134.084 51.435
202109 48.366 135.847 59.585
202112 53.660 138.161 65.000
202203 51.848 138.822 62.506
202206 63.021 142.347 74.094
202209 57.910 144.661 66.996
202212 49.226 145.763 56.519
202303 31.985 146.865 36.448
202306 40.599 150.280 45.213
202309 40.185 151.492 44.393
202312 42.778 152.924 46.815
202403 39.056 153.035 42.711
202406 42.214 155.789 45.349
202409 40.404 157.882 42.829
202412 41.464 158.323 43.830
202503 43.433 157.552 46.136
202506 43.742 159.755 45.824
202509 44.301 162.289 45.684
202512 36.487 163.281 37.398
202603 56.613 164.272 57.676
202606 47.069 167.357 47.069

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹161.94 mean?
Natural Capsules (BOM:524654) has a Cyclically Adjusted Revenue per Share of ₹161.94 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Natural Capsules and its competitors.
Is Natural Capsules' Cyclically Adjusted Revenue per Share too high?
Natural Capsules' current Cyclically Adjusted Revenue per Share is ₹161.94. Overall, Natural Capsules has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Natural Capsules' Cyclically Adjusted Revenue per Share compare to ZTS?
Natural Capsules' Cyclically Adjusted Revenue per Share of ₹161.94 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Natural Capsules and its competitors. Natural Capsules's current Cyclically Adjusted Revenue per Share is ₹161.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Natural Capsules stock overvalued right now?
Based on GuruFocus' analysis, Natural Capsules (BOM:524654) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹296.93, compared to a current price of ₹226.05 — trading 23.9% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹161.94. Natural Capsules' overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Natural Capsules (BOM:524654), the current Cyclically Adjusted Revenue per Share is ₹161.94 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Natural Capsules (BOM:524654) Overvalued in 2026?

Based on GuruFocus' analysis, Natural Capsules stock appears to be undervalued. The current stock price of ₹226.05 is trading 23.9% below its estimated GF Value™ of ₹296.93. GuruFocus considers Natural Capsules to be Modestly Undervalued.

Key valuation signals for BOM:524654:

  • Cyclically Adjusted Revenue per Share: ₹161.94
  • GF Value™: ₹296.93 vs. price of ₹226.05 (23.9% below fair value)
  • GF Score™: 49/100 with 5 warning signs

No single metric tells the full story. See the BOM:524654 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Natural Capsules Business Description

Other Exchanges NATCAPSUQ:India
Address 100 Feet Road, Jayanagar II Block, Trident Towers, 4th Floor, No. 23, Bengaluru, KA, IND, 560 011
Natural Capsules Ltd is an India-based company engaged in the manufacturing and selling of empty hard gelatin capsules. The products of the company are Hard gelatin capsule shells, Hard cellulose capsule shells, Shiny gelatin capsule shells, Sweet gelatin capsule shells, Enteric capsule shells, Printed gelatin capsule shells, Vegetarian capsule shells, Fortified gelatin capsule shells, and other capsules. It is also involved in formulating pharmaceutical dosage forms in capsule dosage form, both pharma and nutraceutical products.
49GF Score

Get the complete analysis for BOM:524654

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹226.05
Price
₹296.93
GF Value